| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.92B | 38.74B | 31.13B | 21.82B | 18.05B | 14.11B |
| Gross Profit | 26.79B | 29.14B | 20.83B | 12.19B | 7.03B | 8.66B |
| EBITDA | 11.10B | 19.22B | 13.90B | 6.09B | 7.63B | 5.80B |
| Net Income | 8.50B | 10.54B | 8.05B | 2.36B | 4.41B | 2.92B |
Balance Sheet | ||||||
| Total Assets | 239.94B | 293.63B | 244.91B | 211.75B | 175.88B | 101.76B |
| Cash, Cash Equivalents and Short-Term Investments | 162.16B | 208.73B | 54.67B | 126.23B | 23.04B | 14.28B |
| Total Debt | 141.82B | 179.56B | 150.73B | 139.48B | 116.16B | 54.76B |
| Total Liabilities | 162.23B | 213.16B | 177.21B | 162.94B | 129.08B | 60.09B |
| Stockholders Equity | 70.76B | 73.49B | 66.84B | 47.86B | 45.78B | 41.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.94B | -10.81B | -18.16B | -49.08B | 24.07B |
| Operating Cash Flow | 0.00 | 11.07B | -10.11B | -18.10B | -48.94B | 24.15B |
| Investing Cash Flow | 0.00 | -4.75B | 13.49B | 3.94B | -9.27B | -18.21B |
| Financing Cash Flow | 0.00 | 25.37B | 19.42B | 21.26B | 66.59B | -15.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥78.61B | 21.69 | ― | 2.02% | 13.52% | 7.75% | |
81 Outperform | ¥25.37B | 17.71 | ― | 2.50% | 16.70% | 22.23% | |
72 Outperform | ¥3.15B | 3.97 | ― | 2.04% | 12.86% | -63.06% | |
69 Neutral | ¥439.31B | 16.35 | 14.42% | 4.80% | 10.39% | 12.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥122.84B | 11.70 | ― | 2.74% | 40.68% | 284.36% | |
56 Neutral | ¥73.13B | 12.85 | ― | 2.44% | 15.20% | -16.02% |